The World Health Organization has announced a plan to distribute the COVID-19 vaccine

Since the widely available COVID-19 vaccine is likely to be permanently close, the initial limitations in supply have left experts wondering: Who gets this vaccine first?

The World Health Organization has announced a plan to distribute the COVID-19 vaccine

The World Health Organization (WHO) and its Strategic Advisory Group on Immunization Specialists, or SEG, have released a plan to distribute the vaccine worldwide - emphasizing the so-called nationalism of the vaccine. According to the idea that every country should give priority to its citizens.

Instead, the WHO influences global practices, prioritizing vaccination among the most vulnerable people everywhere.

"The first priority will be to vaccinate some people in all countries, rather than all people in some countries," said Dr. Tedros Adhanom Ghebreyesus, director general of the WHO in Geneva on Friday. "Vaccine nationalism will prolong the epidemic, not shorten it."

The WHO's proposed vaccine distribution framework ensures that once the novel coronavirus vaccine is available, it is available. Participants in high- and middle-income countries, also known as "self-financing", will provide funding for the Vaccine Accelerator program, summarized as COVAX, knowing that the long-term goal is global prosperity. ۔

This week, along with Germany, Japan, Norway and the European Commission, Germany, Japan, Norway and the European Commission have expressed interest in participating in the CovAX facility as countries of this financial cooperation. So far, a total of 170 countries plan to participate in the Caucus, representing 70% of the world's population. The United States is not one of them.

The doctor said, "The idea behind the coax facility is that the international community should unite in an enlightened and selfish way to encourage both and then distribute the vaccine so that there is no country in the world where no one from the beginning. No vaccine available. “Ruth Faden, PhD, MPH, founder of the Johns Hopkins Bremen Institute for Bioethics. Countries that finance themselves are helping the world by helping themselves."

In addition to strategies for equitable distribution among countries, the WHO framework also reviews vaccination priorities within each country.

In contrast, last week a committee that advises U.S. Centers for Disease Control and Prevention proposed four consecutive steps to prioritize vaccines within the United States, beginning with health-related health. From caregivers, people with serious medical conditions and seniors living in crowded facilities.

The WHO guidelines do not include the order in which specific groups will receive the vaccine, but the plan highlights some vulnerable groups as a top priority of global impact, with each country's There is some flexibility based on unique needs.

"We didn't specifically say who should be the first, second and third group first. It will come later. Not much time, but it will come later," he added. The Framework assists in consulting as a group member but does not represent an international agency.

Faden added that local delivery patterns, the general volume of vaccine supplies and the country's infrastructure would affect the distribution strategy. This is likely to change between now and when a vaccine is approved’ so as more information becomes available, the Sage Group will begin to prioritize specific groups.

A possible example of a flexible framework is how children will be considered’ for vaccination.

"There is a lot of focus in the structure of our values ​​around the negative effects that epidemics have on the well-being of children - 1.5 billion children are out of school," Faden said. "It's just amazing, globally, the number of children whose lives have been affected. The goal is to get children into school as soon as possible.

"When this vaccine becomes available, it may be that the first line strategy is to vaccinate children, not teachers and school staff, just because the data will come first in adults." "

In the United States, Pfizer / Biontech recently announced plans to increase testing in 16-year-olds.

"The WHO framework is particularly noteworthy for its emphasis on global integration with specific goals for rich countries. ... This framework covers not only the public health effects of vaccine distribution, but also social And the economic implications have been considered. "


The T-Rex skeleton can fetch a record price at a New York auction